SCHEMBL6595996

SCHEMBL6595996

O=C1N=CNC1(c1ccccc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 4/20 0.44
BLM P54132 2/20 0.44
PMP22 Q01453 2/20 0.44
HRH1 P35367 2/20 0.44
ALDH1A1 P00352 2/20 0.44
CACNA1F O60840 1/20 0.44
MAPT P10636 1/20 0.44
HTR2A P28223 1/20 0.44
SCN1A P35498 1/20 0.44
SCN4A P35499 1/20 0.44
CACNA1D Q01668 1/20 0.44
KCNH2 Q12809 1/20 0.44
CACNA1S Q13698 1/20 0.44
CACNA1C Q13936 1/20 0.44
SCN5A Q14524 1/20 0.44
SCN2A Q99250 1/20 0.44
SCN3A Q9NY46 1/20 0.44
AKR1B1 P15121 1/20 0.37
LMNA P02545 2/20 0.36
KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13934607 0.78 ALDH1A1 (0.44) CYP2C9BLMPMP22HRH1ALDH1A1
SCHEMBL11836878 0.68 CYP2C9 (0.50) CYP2C9BLMPMP22HRH1ALDH1A1
SCHEMBL4782380 0.65 CYP2C9 (0.47) CYP2C9BLMPMP22HRH1ALDH1A1
SCHEMBL7327872 0.64 BACE1 (0.46) CYP2C9BLMPMP22HRH1ALDH1A1
Phenytoin SCHEMBL29415216 0.63 CYP2C9 (0.49) CYP2C9BLMPMP22HRH1ALDH1A1
SCHEMBL852005 0.62 BACE1 (0.36) CYP2C9BLMPMP22HRH1ALDH1A1
Phenytoin SCHEMBL5499612 0.61 CYP2C9 (1.00) CYP2C9BLMPMP22HRH1ALDH1A1
Phenytoin SCHEMBL3440 0.61 CYP2C9 (1.00) CYP2C9BLMPMP22HRH1ALDH1A1
SCHEMBL8665106 0.61 ALDH1A1 (0.42) CYP2C9BLMPMP22HRH1ALDH1A1
SCHEMBL325055 0.60 CYP2C9 (0.46) CYP2C9BLMPMP22HRH1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1066278-A4 IMIDAZOLONE ANORECTIC AGENTS: III. HETEROARYL DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2004-09-01 EP disclosed
EP-1066262-A4 IMIDAZOLONE ANORECTIC AGENTS: I. ACYCLIC DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2004-09-01 EP disclosed
EP-1066278-A1 IMIDAZOLONE ANORECTIC AGENTS: III. HETEROARYL DERIVATIVES Bristol-Myers Squibb Company (US) 2001-01-10 EP disclosed
EP-1066262-A1 IMIDAZOLONE ANORECTIC AGENTS: I. ACYCLIC DERIVATIVES Bristol-Myers Squibb Company (US) 2001-01-10 EP disclosed
US-6096745-A EATING DISORDERS BRISTOL-MYERS SQUIBB CO. (US) 2000-08-01 US disclosed
US-6063934-A Imidazolone anorectic agents: 1. 2-substituted-3,5-dihydro-5,5-diphenyl-4H-imidazol-4-ones BRISTOL-MYERS SQUIBB COMPANY (US) 2000-05-16 US disclosed
WO-1999048887-A1 IMIDAZOLONE ANORECTIC AGENTS: III. HETEROARYL DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 1999-09-30 WO disclosed
WO-1999048873-A1 IMIDAZOLONE ANORECTIC AGENTS: I. ACYCLIC DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 1999-09-30 WO disclosed
EP-0859762-A1 CYTOKINE PRODUCTION INHIBITORS, FORMULATIONS THEREOF AND THEIR USE IN MEDICINE, AND METHODS FOR THEIR IDENTIFICATION WIVENHOE TECHNOLOGY LIMITED (GB) 1998-08-26 EP disclosed
WO-1997045417-A1 CYTOKINE PRODUCTION INHIBITORS, FORMULATIONS THEREOF AND THEIR USE IN MEDICINE, AND METHODS FOR THEIR IDENTIFICATION WIVENHOE TECHNOLOGY LIMITED (GB) 1997-12-04 WO disclosed